TABLE 13. Number and percentage of reported abortions, by known weeks of gestation and method type — selected reporting areas,* United States, 2021.
| Method type | Weeks of gestation |
Total |
||||||
|---|---|---|---|---|---|---|---|---|
| ≤6 |
7–9 |
10–13 |
14–15 |
16–17 |
18–20 |
≥21 |
||
| No. (%)† | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | |
|
Surgical§
| ||||||||
| ≤13 weeks’ gestation |
62,022 (29.4) |
65,151 (38.4) |
47,263 (79.4) |
NA |
NA |
NA |
NA |
174,436 (37.1)
|
| >13 weeks’ gestation |
NA |
NA |
NA |
12,418 (98.6) |
7,017 (98.0) |
6,455 (96.6) |
3,222 (86.6) |
29,112 (6.2)
|
|
Medication¶
| ||||||||
| ≤9 weeks’ gestation |
148,635 (70.6) |
104,643 (61.6) |
NA |
NA |
NA |
NA |
NA |
253,278 (53.9)
|
| >9 weeks’ gestation |
NA |
NA |
12,231 (20.6) |
158 (1.3) |
122 (1.7) |
207 (3.1) |
458 (12.3) |
13,176 (2.8)
|
|
Intrauterine instillation
|
—** |
—** |
7 (0.0) |
16 (0.1) |
16 (0.2) |
16 (0.2) |
37 (1.0) |
92 (0.0)
|
|
Hysterectomy or hysterotomy
|
21 (0.0) |
20 (0.0) |
7 (0.0) |
1 (0.0) |
5 (0.1) |
6 (0.1) |
3 (0.1) |
63 (0.0)
|
| Total | 210,678 (100.0) | 169,814 (100.0) | 59,508 (100.0) | 12,593 (100.0) | 7,160 (100.0) | 6,684 (100.0) | 3,720 (100.0) | 470,157 (100.0) |
Abbreviation: NA = not applicable.
* Data from 40 reporting areas; excludes 12 reporting areas (California, Connecticut, District of Columbia, Illinois, Maryland, Massachusetts, Missouri, New Hampshire, New Jersey, New York State, Pennsylvania, and Wisconsin) that did not report, did not report by weeks of gestation, did not meet reporting standards, or did not have medication abortion as a specific category on their reporting form.
† For each gestational age category, percentages of all method types might not add to 100% because of rounding.
§ Includes uterine aspiration (might also be called dilation and curettage, aspiration curettage, suction curettage, manual vacuum aspiration, menstrual extraction, sharp curettage) and dilation and evacuation procedures.
¶ The administration of medication or medications to induce an abortion; at ≤9 weeks’ gestation, typically involves the use of mifepristone and misoprostol; at >9 weeks’ gestation, typically involves the use of vaginal prostaglandins.
** Intrauterine instillations reported at ≤12 weeks’ gestation have not been included with known values.